Close menu




January 21st, 2020 | 13:48 CET

Aphria, Cronos Group, EXMceuticals - it is a buyers' market!

  • Cannabis
Photo credits: pixabay.com

The shares of numerous well-known and unknown cannabis companies have had a dramatic year 2019. Price losses of over 50% are not uncommon. What costs only half today may have become twice as attractive. Due to the large number of cannabis companies listed on the stock exchange, this is the time for investors who are planning a new investment.

time to read: 1 minutes | Author: Mario Hose
ISIN: CA03765K1049 , CA22717L1013 , CA30207T1049

Table of contents:


    Emergence of a market

    Among the well-known companies in the cannabis industry are Aphria, Aurora Cannabis, Canopy Growth and also Cronos Group. In the past year new names also came onto the market, but in connection with the price losses of the big players they received little attention or suffered collateral damage.

    So it may be more worthwhile than ever to put newcomers like EXMceuticals on the watch list. The cannabis market is in the development phase and in the course of this, changes in legislation around the globe as well as in the product range will be visible.

    Education and pioneering work

    The large companies such as Aphria and Cronos Group have done a lot of pioneering work in their home country Canada and in many other regions around the globe in recent years. Although the cannabis plant is an ancient remedy, the worldwide wave of legalization has made extensive educational work necessary for politicians, medicine and potential customers.

    The confidence in new therapies does not come overnight and it requires a lot of understanding and patience to build a market for a new product universe.

    EXMceuticals is building a team of experts

    Compared to Aphria and Cronos Group, EXMceuticals is still in a development phase. CEO Jonathan Summers has announced numerous new additions to the team in recent months to develop the operational business with experts who have both experience and an established network.

    Although EXMceuticals is headquartered in Canada, due to a shell acquisition, the operational business is located in Europe and Africa.

    Entry level at low

    Aphria is valued at CAD 1.8 billion market capitalization at a stock market price of CAD 7.02. The shares of Cronos Group changed hands most recently at CAD 11.27 and are valued at CAD 3.9 billion. EXMceuticals is still a lightweight with a market capitalization of 16.5 million CAD at a price of 0.45 CAD, but there is still the opportunity to enter at a low valuation level in order to profit from further developments. As is well known, the profit lies in purchasing.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Stefan Feulner on May 6th, 2024 | 07:00 CEST

    Canopy Growth, Globex Mining and Rock Tech Lithium with strong signals

    • Mining
    • Gold
    • Silver
    • Cannabis
    • Lithium

    Now that the precious metals gold and silver are taking a breather after a rally, other markets are becoming the focus of investor interest. In addition to copper, which is likely to reach new highs in the medium term due to supply shortages, lithium, an industrial metal essential for electromobility, continues to work on bottoming out. However, the highlight of the past week in terms of volatility was cannabis stocks, which are expected to remain in focus in the coming weeks.

    Read

    Commented by Fabian Lorenz on March 28th, 2024 | 08:55 CET

    Shares on a high: Up to 300% with Canopy Growth, Super Micro Computer, Aspermont

    • Technology
    • Digitization
    • Cannabis

    Is the German cannabis market on the verge of a tenfold increase? The head of Canopy Growth thinks so. The Company wants to profit from the boom. Canopy shares have already benefited and more than doubled. What are the Company's plans here in Germany? Super Micro Computer shares have already multiplied, but analysts remain bullish. Growth is expected to remain high. Aspermont offers a hot turnaround story. The B2B media company for the raw materials industry has freed itself from legacy burdens and now aims to grow more strongly again. Analysts see a high free cash flow and 300% share price potential!

    Read

    Commented by Stefan Feulner on March 19th, 2024 | 07:15 CET

    Nvidia, Manuka Resources, Aurora Cannabis - All the rage

    • Mining
    • Vanadium
    • Gold
    • AI
    • chips
    • Cannabis

    The stock markets continue to boom. The DAX was able to climb above the psychologically important 18,000-point mark, at least in the short term, while other asset classes, such as gold and Bitcoin, also reached new highs. By contrast, different sectors, such as hydrogen and cannabis, have continued to plummet in recent weeks. The latter, in particular, has received an upward boost from the US government's statements, which could herald a trend reversal.

    Read